Licensed Product-Related Regulatory Interactions Clause Samples

Licensed Product-Related Regulatory Interactions. From and after the Research Completion Date, as between the Parties, Lilly shall be solely responsible for any communications with any Regulatory Authorities regarding the Licensed Products. In the event that Sigilon receives any communication from a Regulatory Authority following the Research Completion Date, Sigilon shall refer such Regulatory Authority to Lilly and shall not otherwise communicate with such Regulatory Authority without Lilly’s prior written consent.
View SourceView Similar (2)
Licensed Product-Related Regulatory Interactions. NOVODX shall be solely responsible for any communications with any Regulatory Authorities regarding the Licensed Product. In the event that CARING receives any communication directly from a Regulatory Authority regarding Licensed Products being developed, commercialized, or otherwise exploited, by or on behalf of CARING, then CARING shall immediately furnish a copy of the communication to NOVODX, and CARING shall not respond to the communication or take any action without first consulting with NOVODX and obtaining the prior concurrence of NOVODX to the proposed response.
View SourceView Similar (2)
Licensed Product-Related Regulatory Interactions. Affini-T shall be solely responsible for any communications with any Regulatory Authorities regarding the Licensed Products. In the event that Metagenomi receives any communication from a Regulatory Authority regarding a Licensed Product, Metagenomi shall refer such Regulatory Authority to Affini-T and shall not otherwise communicate with such Regulatory Authority without Affini-T’s prior written consent. Affini-T shall have the right to require that Metagenomi make available (at Metagenomi’s cost and expense) an appropriate representative to be present, as a silent observer (except as Affini-T may expressly authorize otherwise), during a meeting or substantive telephone conference call with any Regulatory Authorities relating to Metagenomi Reagents.
View Source

Related to Licensed Product-Related Regulatory Interactions

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.